Track VBI Vaccines's long-term debt ($1.1M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
VBI Vaccines (VBIV) currently reports a long-term debt of $1.1M as of March 2024. That compares with $51M in the prior-year period — down 97.8% year over year. Use the charts on this page to explore VBI Vaccines's long-term debt history and peer comparisons.
VBI Vaccines's long-term debt decreased from $51M to $1.1M — a 97.8% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
VBI Vaccines reported $1.1M in long-term debt as of March 2024. That compares with $51M in the prior-year period — down 97.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for VBI Vaccines, and consider following VBIV for alerts when major investors trade the stock.
VBI Vaccines is classified in the Healthcare sector. On long-term debt, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBIV with unrelated industries.